Sustained Effect of Urticaria Remission With Relatively High Dose Vitamin D Supplementation After Omalizumab Discontinuation

NCT02742805 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Urticaria

Interventions

DIETARY_SUPPLEMENT: Vitamin D (4,000 IU/day)
DIETARY_SUPPLEMENT: Vitamin D (400 IU/day)
DRUG: Omalizumab

Sponsor

Selina Gierer, D.O.